Application

ADAXIQ

Revance Therapeutics, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97386557
Filing Date: 04/28/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97386557
MARK INFORMATION
*MARK ADAXIQ
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ADAXIQ
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Revance Therapeutics, Inc.
INTERNAL ADDRESS 20th Floor
*MAILING ADDRESS 1222 Demonbreun St
*CITY Nashville
*STATE
(Required for U.S. applicants)
Tennessee
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
37203
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Maren C. Perry
ATTORNEY DOCKET NUMBER 13720.104045
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME King & Spalding LLP
STREET 1185 Avenue of the Americas
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10036
PHONE 212-556-2128
FAX (212) 556-2222
EMAIL ADDRESS nytrademarks@kslaw.com
OTHER APPOINTED ATTORNEY Kathleen E. McCarthy
CORRESPONDENCE INFORMATION
NAME Maren C. Perry
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE nytrademarks@kslaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) mperry@kslaw.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /mcp/
SIGNATORY'S NAME Maren C. Perry
SIGNATORY'S POSITION Attorney of Record, New York Bar member
SIGNATORY'S PHONE NUMBER 212-556-2128
DATE SIGNED 04/28/2022
SIGNATURE METHOD Signed directly within the form



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97386557
Filing Date: 04/28/2022

To the Commissioner for Trademarks:

MARK: ADAXIQ (Standard Characters, see mark)
The literal element of the mark consists of ADAXIQ. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Revance Therapeutics, Inc., a corporation of Delaware, having an address of
      20th Floor
      1222 Demonbreun St
      Nashville, Tennessee 37203
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Maren C. Perry. Other appointed attorneys are Kathleen E. McCarthy. Maren C. Perry of King & Spalding LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      1185 Avenue of the Americas
      New York, New York 10036
      United States
      212-556-2128(phone)
      (212) 556-2222(fax)
      nytrademarks@kslaw.com
The docket/reference number is 13720.104045.
Maren C. Perry submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Maren C. Perry
       PRIMARY EMAIL FOR CORRESPONDENCE: nytrademarks@kslaw.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): mperry@kslaw.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /mcp/   Date: 04/28/2022
Signatory's Name: Maren C. Perry
Signatory's Position: Attorney of Record, New York Bar member
Signatory's Phone Number: 212-556-2128
Signature method: Signed directly within the form
Payment Sale Number: 97386557
Payment Accounting Date: 04/28/2022

Serial Number: 97386557
Internet Transmission Date: Thu Apr 28 14:47:35 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.XX-2022042814473526
1507-97386557-8205a983f4dbbabe0333aa222c
c4ddb4de2337e539d9eef627a2fd769727f8-DA-
47352054-20220428144559131545

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed